Company Team Projects Media Contact


Investing in biomedical discoveries

LASCCO SA is a biomedical-technology development private company based in Geneva, Switzerland. The primary objective of LASCCO is to bring promising early-stage biomedical technologies – therapeutics and diagnostics – developed in research institutes to the attention of the pharmaceutical industry.




Positive Topline Results from First-in-Man Trial with CAL02 in the Treatment of Severe Pneumonia - 17/04/2018

Combioxin Announces Completion of CAL02 FIM Trial in Patients with Severe Pneumococcal Pneumonia - 29/03/2018